Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for LUTS and Detrusor Activity in BPH
NCT02245490Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2003
- Primary completion
- Apr 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Changes in mean number of micturitions per day at 12 weeks. Started Jan 2003; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT02245490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245490.